Best in Biotech 14 Mar 2024
7 oncolytic virus companies you should know about
…(T-SIGn) platform to deliver novel immunotherapeutic proteins, biomolecules, and transgene combinations to treat solid tumors. The company’s portfolio is made up of solid tumor-targeted T-SIGn therapeutics that aim to enable…